Understanding how a key Parkinson's disease protein organizes its cellular partnerships could reshape how researchers design drugs targeting the condition — particularly for the millions carrying LRRK2 risk variants who currently lack mechanism-informed therapies.
Using BioID proximity labeling, investigators mapped the full protein neighborhood of LRRK2 — a multidomain kinase implicated in both familial and sporadic Parkinson's disease — and then layered co-evolutionary and AlphaFold-Multimer structural modeling onto that interaction map. The integrated pipeline uncovered a previously unappreciated module of LRRK2 interactors that clusters around centrosomes and microtubule-associated cytoskeletal machinery. Critically, the composition of this interaction network proved highly dynamic: exposure to the type I kinase inhibitor MLi-2 or forced co-expression of the upstream regulator RAB29 each produced distinct rearrangements in LRRK2's protein neighborhood, tying specific conformational states to discrete subcellular compartments — including centriolar satellites and vesicular domains.
This work intersects two maturing fields: proximity proteomics, which has transformed our ability to capture transient or context-dependent interactions, and structure-prediction tools like AlphaFold-Multimer that allow hypothesis generation at the interaction interface level. The centrosome linkage is particularly interesting because centriolar satellites are known hubs for protein quality control and ciliary signaling — pathways with growing relevance to neurodegeneration. However, the findings are entirely cell-based, and mapping a protein interaction network, however sophisticated, does not establish causality for any specific disease mechanism. The conformational dependency of LRRK2 interactions — where inhibitor binding reshuffles the interactome — has direct pharmacological implications: it suggests current kinase inhibitors may inadvertently rewire cellular compartmentalization beyond simply suppressing catalytic output. Whether this network reorganization is beneficial, neutral, or harmful in neurons remains an open and urgent question. Overall, this is a technically sophisticated, hypothesis-generating study that will likely accelerate target prioritization in LRRK2 biology.